# AME Study of [14C]-PC14586 in Healthy Male Participants

> **NCT05523687** · PHASE1 · COMPLETED · sponsor: **PMV Pharmaceuticals, Inc** · enrollment: 8 (actual)

## Conditions studied

- Healthy Male Volunteers

## Interventions

- **DRUG:** [14C]-PC14586

## Key facts

- **NCT ID:** NCT05523687
- **Lead sponsor:** PMV Pharmaceuticals, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-09-06
- **Primary completion:** 2022-11-30
- **Final completion:** 2022-11-30
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2022-12-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05523687

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05523687, "AME Study of [14C]-PC14586 in Healthy Male Participants". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT05523687. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*